Efficacy and safety of empagliflozin: a “real-world” experience from Saudi Arabia
BACKGROUND: Sodium-glucose cotransporter 2 (SGLT2) inhibitors are new agents for treating type 2 diabetes. In addition to the glycemic benefits, these agents provide cardiorenal protection in patients with diabetes and without diabetes. There is consistent evidence that these agents increase the ris...
Na minha lista:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
King Faisal Specialist Hospital and Research Centre
2023-01-01
|
| coleção: | Annals of Saudi Medicine |
| Acesso em linha: | http://www.annsaudimed.net/doi/10.5144/0256-4947.2023.50 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|